Investors / China / TF Capital
TF Capital
Venture capital · Shanghai, China · Asia Pacific
TF Capital is an investment firm focused on innovative biotech in China, describing itself as a first and foremost investor partnering with early-stage innovators. It provides capital and strategic expertise across the full value chain, with $1B in assets under management and over 100 portfolio companies.
Invests inHealthcare & Biotech
In its own wordsbiotechbiopharmahealthcareearly-stage
Your fit with TF Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsTF Capital lists 13 checked portfolio companies on its own site and is named in 4 funding rounds. Its most frequent entry is Series B, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (85%), Robotics & Hardware (8%) and AI & Machine Learning (8%). 67% of its companies are based in China. It invests most often alongside Qiming Venture Partners, Amazon Industrial Innovation Fund and Andra Capital.
Counts come from funding rounds that name TF Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not TF Capital's whole history. Rounds on record name 4 companies; its own site lists 13. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 25% |
| Series B | 50% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 33th | 13 companies |
| Recent activity | 76th | 3 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 94th | 85% in its largest sector |
| Reach | 59th | 3 countries |
Invests most often with
firms sharing its portfolio companies
Amazon Industrial Innovation Fund
1Show as a table
| Share | |
|---|---|
| Qiming Venture Partners | 4 |
| Amazon Industrial Innovation Fund | 1 |
| Andra Capital | 1 |
| Berkeley Frontier Fund | 1 |
| Blue Ocean Capital Group | 1 |
| CRV | 1 |
| Casdin Capital | 1 |
| Coatue | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers13100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 85% | 15% |
| Robotics & Hardware | 8% | 1% |
| AI & Machine Learning | 8% | 18% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Qiming Venture Partners
Compare TF Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backvs Amazon Industrial Innovation Fund1 shared company→Three or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with TF Capital| Date | Company | Stage |
|---|---|---|
| 14 Jan 2026 | Series C+ | |
| 22 Sept 2025 | Series B |
Round details for TF Capital
Amounts, full round histories and every co-investor in TF Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
13 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Antengene is a company that discovers, develops, manufactures, and commercializes therapies, with a focus on hematologic malignancies and solid tumors. | Healthcare & Biotech | Portfolio page | ||
| Asieris develops and commercializes innovative therapies in genitourinary tumors and women's health | Healthcare & Biotech | Portfolio page | ||
| Avenzo Therapeutics develops next-generation oncology therapies to transform cancer treatment | Healthcare & Biotech | Sept 2025Series B | Funding round | |
| Portfolio page | ||||
| DreamCIS provides clinical trial and consulting services for therapeutic areas such as oncology, cardiovascular, and rare disease | Healthcare & Biotech | Portfolio page | ||
| Frontage Laboratories provides pharmaceutical development services, including laboratory testing, drug discovery, and clinical services. | Healthcare & Biotech | Portfolio page | ||
| GenFleet Therapeutics develops innovative drugs, focusing on unmet clinical needs in the fields of tumors and immune diseases. | Healthcare & Biotech | Portfolio page | ||
| HighTide Therapeutics focuses on developing therapeutic solutions for cardiovascular-kidney-metabolic diseases | Healthcare & Biotech | Portfolio page | ||
| Pegbio is a biotechnology company that researches and develops innovative therapies for chronic diseases, particularly in the field of endocrine metabolism. | Healthcare & Biotech | Portfolio page | ||
| PharmaResources is a comprehensive one-stop service provider for new drug R&D as well as commercial production | Healthcare & Biotech | Portfolio page | ||
| The company provides medical products and solutions. | Healthcare & Biotech | Portfolio page | ||
| Skild Ai builds artificial intelligence to control robots for various tasks in the physical world | Robotics & HardwareAI & Machine Learning | Jan 2026Series C+ | Funding round | |
| Zai Lab is a biopharmaceutical company that discovers, develops, and commercializes innovative products to address medical conditions with significant unmet needs | Healthcare & Biotech | Portfolio page |
About this data
site last read 7 Nov 2026- Site
- tfcapital.net
- Last read
- 7 Nov 2026
- Watching since
- 7 Nov 2026
- Rounds since
- 22 Sept 2025
- Companies checked
- 13
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get TF Capital's profile as data
Pull TF Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/tfcapital.net
# also
GET /v1/firms/tfcapital.net/portfolio
GET /v1/firms/tfcapital.net/coinvestors
GET /v1/firms/tfcapital.net/news